U.S. Top Stock Picks from Analysts

JD.com

Market Cap: US$45.3b

Operates as a supply chain-based technology and service provider in the People’s Republic of China.

Summit Therapeutics

Market Cap: US$15.3b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

BioMarin Pharmaceutical

Market Cap: US$10.5b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Moderna

Market Cap: US$10.0b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Aurora Innovation

Market Cap: US$9.2b

Operates as a self-driving technology company in the United States.

Sociedad Química y Minera de Chile

Market Cap: US$9.2b

Operates as a mining company worldwide.

CAVA Group

Market Cap: US$8.6b

Owns and operates a chain of restaurants under the CAVA brand in the United States.

Pegasystems

Market Cap: US$8.5b

Develops, markets, licenses, hosts, and supports enterprise software in the United States, rest of the Americas, the United Kingdom, rest of Europe, the Middle East, Africa, and the Asia-Pacific.

VinFast Auto

Market Cap: US$7.9b

Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.

Corcept Therapeutics

Market Cap: US$7.6b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Revolution Medicines

Market Cap: US$7.4b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

GitLab

Market Cap: US$6.7b

Develops software for the software development lifecycle in the United States, Europe, and the Asia Pacific.

Repligen

Market Cap: US$6.7b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

ZEEKR Intelligent Technology Holding

Market Cap: US$6.6b

An investment holding company, engages in the research and development, production, commercialization, and sale of the electric vehicles and batteries.

Jazz Pharmaceuticals

Market Cap: US$6.5b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

UWM Holdings

Market Cap: US$6.5b

Engages in the origination, sale, and servicing residential mortgage lending in the United States.

Legend Biotech

Market Cap: US$6.3b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Ionis Pharmaceuticals

Market Cap: US$6.0b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Caesars Entertainment

Market Cap: US$5.9b

Operates as a gaming and hospitality company.

Clearwater Analytics Holdings

Market Cap: US$5.7b

Develops and provides a Software-as-a-Service (SaaS) solution for automated investment data aggregation, reconciliation, accounting, and reporting services to insurers, investment managers, corporations, institutional investors, and government entities in the United States and internationally.

Lantheus Holdings

Market Cap: US$5.5b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

GDS Holdings

Market Cap: US$5.4b

Develops and operates data centers in the People's Republic of China.

ChampionX

Market Cap: US$5.0b

Provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide.

Axsome Therapeutics

Market Cap: US$5.0b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Onto Innovation

Market Cap: US$4.7b

Engages in the design, development, manufacture, and support of process control tools that performs optical metrology and inspection worldwide.

BGC Group

Market Cap: US$4.4b

Operates as a financial brokerage and technology company in the United States, Europe, the Middle East, Africa, and the Asia Pacific.

Vaxcyte

Market Cap: US$4.2b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

ADMA Biologics

Market Cap: US$4.2b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Pony AI

Market Cap: US$4.2b

Through its subsidiaries, engages in the autonomous mobility business in the People’s Republic of China and the United States.

CRISPR Therapeutics

Market Cap: US$4.1b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Merus

Market Cap: US$4.0b

A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.

Cytokinetics

Market Cap: US$3.9b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

Inspire Medical Systems

Market Cap: US$3.9b

A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.

Globant

Market Cap: US$3.9b

Provides technology services worldwide.

Krystal Biotech

Market Cap: US$3.8b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Zai Lab

Market Cap: US$3.8b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.